3 Black Friday Bargains: Barclays PLC, GlaxoSmithKline plc And Tesco PLC

Forget Black Friday, Barclays PLC (LON:BARC), GlaxoSmithKline plc (LON:GSK) and Tesco PLC (LON:TSCO) are the real bargains to buy this week

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s one of the biggest shopping weeks of the year, with Black Friday whipping consumers into a pre-Christmas frenzy by offering huge discounts in the shops.

The FTSE 100 is also throwing up some amazing discounts right now, and they will ultimately make you richer, rather than poorer. Here are my three favourite Black Friday bargains: Barclays (LSE: BARC) (NYSE: BCS.US), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Tesco (LSE: TSCO).

Barclays

At 237p, big bad bank Barclays is down 20% from its 52-week high of 297p… but it is showing signs of a recovery, following a solid 5% rise in Q3 profits to £4.94bn.

Barclays still faces a string of threats, including market rigging penalites, mis-selling scandals, challenger banks, crashing investment bank profits (down 38% in Q3) and an ongoing investigation into the current account market.

It has also shown signs of capital inadequacy, with a £12.8bn hole in its balance sheet. At Barclays, every day seems like Black Friday.

The outlook should slowly brighten as the billions keep rolling in, the dividend yield (now 2.73%) is repaired, and reputational damage finally patched up.

Barclays’ core businesses are delivering a return on equity of 10.5%, driven by personal and corporate banking, and the strength of its market-leading credit card Barclaycard.

These are solid operations, and you can buy them at a discount today.

GlaxoSmithKline

Trading at 1475p, GlaxoSmithKline is still 14% off its 52-week high, but the gap is starting to narrow. Its share price is up 7% in the last month, but it still offers one of the most enticing yields on the FTSE 100.

Glaxo currently yields 5.3%, more than 10 times base rate. Better still, today’s valuation of 13 times earnings (against 15 or 16 times) makes this a true Black Friday bargain.

Falling pharmaceuticals and vaccine sales in the US, disappointments in its consumer healthcare division, and the threat of further action over the Chinese bribery scandal have painted 2014 black for Glaxo. But unlike the bankers, I reckon it will learn its lessons quickly. And while you wait, keep re-investing those dividends.

Tesco

Britain’s biggest supermarket is so cheap it is almost impossible to resist, and even harder to trust. At 195p, its share price is 44% below its 52-week high. Customers hate it, investors hate it, regulators hate it: what’s to like?

Well, it’s under new management, and new boss Dave Lewis has a free hand to turn things round. Staff may go, stores may close, prices may fall and Tesco Bank may be sold off.

Almost anything could happen at Tesco right now. It is quite a gamble, even at 6.1 times earnings, but that’s how it’s is in the sales. You never really know if you’ve bagged a bargain, until you get it home.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Tesco. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »